David Canton, D.O., M.P.H., JD. Chief Medical Officer Shasta - - PowerPoint PPT Presentation

david canton d o m p h jd chief medical officer shasta
SMART_READER_LITE
LIVE PREVIEW

David Canton, D.O., M.P.H., JD. Chief Medical Officer Shasta - - PowerPoint PPT Presentation

David Canton, D.O., M.P.H., JD. Chief Medical Officer Shasta Community Health Center The Start Pain Committee Started in 2012 Developed Primary Care management guidelines Management agreement Informed consent Provide


slide-1
SLIDE 1

David Canton, D.O., M.P.H., JD. Chief Medical Officer Shasta Community Health Center

slide-2
SLIDE 2

The Start

Pain Committee

 Started in 2012

Developed Primary Care management

guidelines

 Management agreement  Informed consent

Provide comfort for Cross coverage

slide-3
SLIDE 3

The Committee

Meetings Make up

6 clinicians including one behavioral

health

Nurses Administrative staff

Authority of the CMO

slide-4
SLIDE 4

Next Step

 Began to look at all Controlled substances

 Benzo’s and their cousins  Marijuana

 Changed name to Safe Prescribing Committee  Set goals for Management Agreement and

tracked

 Set goals for Urine Tox and tracked  Notified patients effected

slide-5
SLIDE 5

Timeline

 February 2014, we sent out 374 letters to patients on

high dose opiates telling them of our new policy.

 April 2014 -- Our first pain brochure was completed  April 2014 -- We revised the Pain Management

Guidelines

 May 2014 – We looked at the average number of visits

  • f patients with and without chronic pain meds, and

tested for significance at the clinician and the Center level.

 Jan 2015 – SCHC pain brochure modified to include No

ethol and marijuana and opiate medications.

slide-6
SLIDE 6

Current functions

 Consultant resources

 Send request to chair  Tapering recommendations  Dosing recommendations  Engagement recommendations

 Monitor compliance

 Monthly monitoring  Medical Director management  Evaluation factor

slide-7
SLIDE 7

Where Are We?

 August 2013: 2969 patients on chronic pain meds, 136

patients on high dose opiates

 January 2014: 3053 patients on chronic pain meds, 358

patients on high dose opiates (the expansion brought in some new patients)

 December 2014 –2875 on chronic pain meds. 386

patients on high dose opiates

 May 2015 – 2652 on chronic pain. About 100 patients

  • n high dose opiates.
slide-8
SLIDE 8

A graphic look at moving from QA to QI

8

Mediocre quality, on average hits the threshold, but a lot of variation Consistent poor quality Good QA – hitting the threshold (on average) Good QI- hitting the threshold consistently, little variation

slide-9
SLIDE 9

0% 20% 40% 60% 80% 100% 8/31/2013 9/21/2013 10/21/2013 11/18/2013 12/16/2013 1/23/2014 2/22/2014 3/22/2014 4/29/2014 5/23/2014 6/23/2014 7/19/2014

Chronic Pain Meds - % with Med Management Agreement

FP-Blue FP-Gold FP-Green HOPE HV AND RES SL SPC UC

July 2014

Numerous report formats “tested”

9

As of June 23, 2014 (Established and No PCC) As of July 19, 2014 (Established and No PCC) Trend- June-July 2014 ** Team Total PAIN Meds PAIN-Has a Med Mgmt contract PAIN-Had a utox % PAIN- has a Med Mgmt contract % PAIN- had a Utox Total PAIN Meds PAIN-Has a Med Mgmt contract PAIN-Had a utox % PAIN- has a Med Mgmt contract % PAIN- had a Utox Change in Number

  • f

Patients Change in % Med Mgmt contract Change in % Utox Established 77 32 30 41.6% 39.0% 93 21 26 22.6% 28.0% ↓ ↓ FP-Blue 87 48 44 55.2% 50.6% 107 44 49 41.1% 45.8% ↓ ↓ FP-Gold 531 288 320 54.2% 60.3% 684 231 371 33.8% 54.2% ↓ ↓ FP-Green 430 333 295 77.4% 68.6% 533 310 363 58.2% 68.1% ↓ − HOPE 20 9 12 45.0% 60.0% 5 1 0.0% 20.0% ↓ ↓ HV 230 205 174 89.1% 75.7% 314 226 237 72.0% 75.5% ↓ ↓ No PCC 84 26 18 31.0% 21.4% 162 23 24 14.2% 14.8% ↓ ↓ PEDS 11 3 3 27.3% 27.3% 14 2 2 14.3% 14.3% ↓ ↓ Purple 265 192 177 72.5% 66.8% 327 193 209 59.0% 63.9% ↓ ↓ RES 494 356 339 72.1% 68.6% 601 319 393 53.1% 65.4% ↓ ↓ SL 379 288 274 76.0% 72.3% 429 261 302 60.8% 70.4% ↓ ↓ SPC 567 376 321 66.3% 56.6% 714 412 409 57.7% 57.3% ↓ − UC 223 110 67 49.3% 30.0% 269 92 79 34.2% 29.4% ↓ − Grand Total 3398 2266 2074 66.7% 61.0% 4252 2134 2465 50.2% 58.0% ↓ ↓

10 20 30 40 50 60 70 80 90 100 Percent 5 10 15 20 25 30 35 40 Percent Chronic Pain Med Patients in Team Panel

With Med Agreement With Utox With PARS Agreement-Utox Pair Agreement-PARS Pair Mar 21 2015.

By Percent in Team Adult Patient Panel Percent Chronic Pain Med Patients with Agreements, Utoxes and PARS

slide-10
SLIDE 10

Are we making progress? Proportion of patients on opioid medications has remained fairly stable

10 20 30 40 % Adult Pain pats' 2015-01-24 2015-02-22 2015-03-21

in PCC Panels Over Time Percent Adult Patients on Chronic Pain Medication

10

Median (50%) 75th percentile 25th percentile Upper value Lowest value

slide-11
SLIDE 11

Proportion of patients with current med management agreements is increasing

20 40 60 80 100 % With Med Agreement 2015-01-24 2015-02-22 2015-03-21

Current Med Management Agreements in PCC Panels Over Time Percent Adult Patients on Chronic Pain Medication with

11

Less variation is

  • good. Means

that teams are more consistently getting/upda ting med management agreements.

slide-12
SLIDE 12

Proportion of patients with current utoxes is increasing

50 60 70 80 90 100 % With Utox 2015-01-24 2015-02-22 2015-03-21

Current Utox in PCC Panels Over Time Percent Adult Patients on Chronic Pain Medication with

12

Less variation is good. Means that teams are more consistently doing utoxes.

slide-13
SLIDE 13

Proportion of patients with current PARS/CURES is increasing

20 40 60 80 100 % With PARS 2015-01-24 2015-02-22 2015-03-21

Current PARS in PCC Panels Over Time Percent Adult Patients on Chronic Pain Medication with

13

More variation is good. Means that teams are getting PARS reports.

slide-14
SLIDE 14

Lessons Learned

Needed a clear (and repeated)

articulation of policies and guidelines

Provided patient information

about the policy

Try out different data

presentations – not all will work, not all will work forever

Enjoy the success

14

slide-15
SLIDE 15

Questions Comments

dcanton@shastahealth.org

David Canton, DO, M.P.H., J.D.